PROLOR Biotech Free Cash Flow:
-5.306M for Dec. 31, 2012PROLOR Biotech Historical Free Cash Flow Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| Dec. 31, 2012 | -5.306M |
| Sept. 30, 2012 | -3.112M |
| June 30, 2012 | -3.628M |
| March 31, 2012 | -4.824M |
| Dec. 31, 2011 | -3.921M |
| Sept. 30, 2011 | -2.056M |
| June 30, 2011 | -3.386M |
| March 31, 2011 | -3.330M |
| Dec. 31, 2010 | -1.999M |
| Sept. 30, 2010 | -1.683M |
| June 30, 2010 | -0.9421M |
| March 31, 2010 | -1.772M |
| Dec. 31, 2009 | -1.030M |
About Free Cash Flow
Free cash flow is the amount of cash generated by a business that is available for distribution among its security holders. Security holders include debt holders, equity holders, preferred stock holders, and convertible security holders. Specifically, free cash flow is used to pay dividends, make acquisitions, develop new products, invest in new property, plant and equipment, pay interest expenses, and reduce debt.
According to many investors, free cash flow is the best indication of a company's ability to generate cash.
Learn More
PBTH Free Cash Flow Benchmarks
| Companies | |
|---|---|
| Opko Health | -6.136M |
| Array BioPharma | -30.05M |
| GTx | -13.95M |
PBTH Free Cash Flow Rankings
| Overall |
55th percentile 3341 of 7593 |
| Sector |
40th percentile 390 of 650 in Healthcare |
| Industry |
60th percentile 93 of 237 in Biotechnology |
PBTH Free Cash Flow Range, Past 5 Years
| Minimum | -5.306M | Dec 2012 |
| Maximum | -0.9421M | Jun 2010 |
| Average | -2.518M |
PBTH News
Law Office of Brodsky & Smith, LLC Announces Investigation of PROLOR Biotech, Inc.
Business Wire Apr 27
Business Wire Apr 27